Abstract

The Major Histocompatibility Complex (MHC) plays an important role in the human immune system. The MHC is involved in the antigen presentation system assisting T cells to identify foreign or pathogenic proteins. However, an MHC molecule binding a self-peptide may incorrectly trigger an immune response and cause an autoimmune disease, such as multiple sclerosis. Understanding the molecular mechanism of this process will greatly assist in determining the aetiology of various diseases and in the design of effective drugs. In the present study, we have used the Fresno semi-empirical scoring function and modify the approach to the prediction of peptide-MHC binding by using open-source and public domain software. We apply the method to HLA class II alleles DR15, DR1, and DR4, and the HLA class I allele HLA A2. Our analysis shows that using a large set of binding data and multiple crystal structures improves the predictive capability of the method. The performance of the method is also shown to be correlated to the structural similarity of the crystal structures used. We have exposed some of the obstacles faced by structure-based prediction methods and proposed possible solutions to those obstacles. It is envisaged that these obstacles need to be addressed before the performance of structure-based methods can be on par with the sequence-based methods.

Highlights

  • Multiple sclerosis (MS) is a neurological disease characterised by inflammation and demyelination in the central nervous system

  • RMSDMHC is the root mean square deviation (RMSD) for the structure of the Major Histocompatibility Complex (MHC) molecule alone, RMSDpeptide is the RMSD for the structure of peptide alone, and the RMSD for the whole structure. doi:10.1371/journal.pone.0025055.t004. In this series of experiments, we have shown that our implementation of the Fresno scoring function, using open source/free software, reproduces the results of Rognan et al and, performs slightly better than the original implementation

  • When the number of reference structures used is reduced to one, the performance of the scoring function is greatly diminished, even if a large set of peptide binding data is used. This indicates that either MHC molecules assume quite different positions whilst binding to different peptides or that the theoretical approach used to predict peptide binding is quite sensitive to small changes in MHC structure

Read more

Summary

Introduction

Multiple sclerosis (MS) is a neurological disease characterised by inflammation and demyelination in the central nervous system. Genetic linkage analyses of MS patients have identified the DRB1*1501 and DQB1*0602 alleles of the Major Histocompatibility Complex (MHC) molecule as definite genetic risk factors [2,5]. This has been confirmed in more recent genome wide association studies [6]. While the overall antigen presentation mechanism is reasonably well understood, the specificity and sensitivity of peptide binding to MHC molecules, and the binding of T-cells to the resultant complex, required to elicit an immune response, is not well defined. Deeper knowledge of the peptide binding process may help to isolate the cause of the disease and detect peptides with therapeutic potential

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call